By Izzy Wood (Drug Target Review)2023-04-12T16:02:32
With advancements in artificial intelligence, precision medicine and gene editing, the field of drug discovery is undergoing a rapid transformation. In this article, Drug Target Review’s Izzy Wood gets the insider knowledge from industry leaders at SLAS 2023, who are experiencing these changes first hand.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-12T09:31:00Z
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-01-06T10:25:33
Sponsored by Leica Microsystems
2023-03-23T14:46:21
Sponsored by Bio-Techne
2024-01-26T13:22:42
Sponsored by bit.bio
Site powered by Webvision Cloud